POMT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.494600E-01
Normal-vs-Stage2
9.584400E-02
Normal-vs-Stage3
8.339700E-02
Normal-vs-Stage4
6.769800E-01
Stage1-vs-Stage2
4.567400E-01
Stage1-vs-Stage3
2.536800E-01
Stage1-vs-Stage4
6.516800E-01
Stage2-vs-Stage3
5.123800E-02
Stage2-vs-Stage4
7.398200E-01
Stage3-vs-Stage4
2.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.614200E-01
Normal-vs-AfricanAmerican
2.643000E-01
Normal-vs-Asian
3.641600E-01
Caucasian-vs-AfricanAmerican
5.154800E-04
Caucasian-vs-Asian
6.590800E-01
AfricanAmerican-vs-Asian
2.803600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.087600E-01
Normal-vs-Female
7.182000E-01
Male-vs-Female
5.617000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.426000E-01
Normal-vs-Age(41-60Yrs)
8.467400E-01
Normal-vs-Age(61-80Yrs)
4.493000E-01
Normal-vs-Age(81-100Yrs)
3.358600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.313200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.583200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.279000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.150200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.465890E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.021800E-02
Normal-vs-Daily Drinker
5.987400E-01
Normal-vs-Weekly Drinker
3.565600E-01
Normal-vs-Occasional Drinker
9.845000E-01
Normal-vs-Social Drinker
9.763400E-01
Non Drinker-vs-Daily Drinker
2.773000E-01
Non Drinker-vs-Weekly Drinker
2.098200E-01
Non Drinker-vs-Occasional Drinker
6.109700E-02
Non Drinker-vs-Social Drinker
1.909160E-01
Daily Drinker-vs-Weekly Drinker
8.792600E-01
Daily Drinker-vs-Occasional Drinker
3.419800E-01
Daily Drinker-vs-Social Drinker
4.755600E-01
Weekly Drinker-vs-Occasional Drinker
2.519400E-01
Weekly Drinker-vs-Social Drinker
4.017000E-01
Occasional Drinker-vs-Social Drinker
9.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.224400E-01
Normal-vs-Grade 2
9.698400E-01
Normal-vs-Grade 3
9.666400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.600200E-02
Grade 1-vs-Grade 3
7.938100E-02
Grade 1-vs-Grade 4
6.224400E-01
Grade 2-vs-Grade 3
9.510200E-01
Grade 2-vs-Grade 4
9.698400E-01
Grade 3-vs-Grade 4
9.666400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.664200E-01
Normal-vs-NonDiabetic
7.897200E-01
Diabetic-vs-NonDiabetic
5.411800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.435950E-01
Normal-vs-NoPancreatitis
7.094600E-01
Pancreatitis-vs-NoPancreatitis
1.506200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.704600E-01
Normal-vs-N1
1.092230E-01
N0-vs-N1
1.289800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.211000E-01
Normal-vs-TP53-NonMutant
9.364200E-01
TP53-Mutant-vs-TP53-NonMutant
1.105950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
